Plaintiffs Win Again In Seroquel MDL Experts Fight
Plaintiffs seeking the admission of expert noncausation testimony in the multidistrict litigation over AstraZeneca Pharmaceuticals LP's antipsychotic Seroquel have largely won another round in the battle over what can be presented...To view the full article, register now.
Already a subscriber? Click here to view full article